Researchers have developed a new suite of genetic tools for cell-type specific targeting to battle brain disease.

Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

Kaida BioPharma is advancing targeted anti-cancer hormonal therapies to address the root cause of cancers affecting women.

A precipitation-based chromatography alternative, a novel viral vector isolation tech, and a glycosylation prediction system are among the projects awarded funding in the latest round of grants issued ...

These microbes produce metabolites that might be used to treat bacterial infections, cancer, type 2 diabetes, and much more.

With several surfactants to choose from, the biopharma industry is still working to identify the most effective, environmentally friendly alternatives to the surfactant Triton X-100 (TX-100). The EU ...

Genmab says choosing to insource cell-line development helped them to improve the antibody titers they were achieving.

This week a group of researchers, bioethicists, publishers and theologians are discussing the merits of human heritable genome editing.

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.